Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xinyi Xia and Rongrong Pang.
Xinyi Xia
Connection Strength
1.375
Rongrong Pang
  1. Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment. Front Immunol. 2021; 12:598799.
    View in: PubMed
    Score: 0.233
  2. 3044 Cases reveal important prognosis signatures of COVID-19 patients. Comput Struct Biotechnol J. 2021; 19:1163-1175.
    View in: PubMed
    Score: 0.232
  3. Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China. J Med Virol. 2021 04; 93(4):2321-2331.
    View in: PubMed
    Score: 0.230
  4. Evolution of COVID-19 in patients with autoimmune rheumatic diseases. Aging (Albany NY). 2020 12 03; 12(23):23427-23435.
    View in: PubMed
    Score: 0.229
  5. Clinical efficacy of convalescent plasma therapy on treating COVID-19 patients: Evidence from matched study and a meta-analysis. Clin Transl Med. 2020 Dec; 10(8):e259.
    View in: PubMed
    Score: 0.229
  6. Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China 'hot spot' versus in US 'hot spot': similarities and differences. Ann Rheum Dis. 2021 05; 80(5):e63.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.